Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
37 pending office actions • 30 art units • 35 examiners • 0 of 37 (0%) have an AI response strategy ready • 46 patents granted in the last 365 days
Kyoto University has 35 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 33 distinct examiners and 28 distinct art units, indicating broad distribution across examination personnel and technical groups. This structure presents a materially different management challenge from a portfolio concentrated in one examiner or art unit.
NELSON, HUNTER JARED is the busiest examiner, with 3 pending matters. That assignment is the largest examiner-specific workload identified, but it remains a limited portion of the overall pending docket. Counsel should use centralized issue tracking, identify recurring claim or prior-art themes across art units, and preserve flexibility for examiner-specific response strategies.
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §101 + other | 2 (5%) |
| §103 only | 10 (27%) |
| §102 only | 1 (3%) |
| §112 only | 2 (5%) |
| Double-patenting + other | 5 (14%) |
| Multi-statute (no §101) | 16 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NELSON, HUNTER JARED | 3 | 37.5% | +26.0% |
| JACKSON, MONIQUE R | 1 | 34.8% | +44.3% |
| SHELLHAMMER, JAMES PAUL | 1 | 10.0% | +18.8% |
| GEMBEH, SHIRLEY V | 1 | 63.1% | +33.8% |
| VASISTH, VISHAL V | 1 | 72.5% | +33.4% |
| ARCORIA, PAUL JOSEPH | 1 | 100.0% | +0.0% |
| SHIAO, REI TSANG | 1 | 79.9% | -33.5% |
| JANSSEN, REBECCA | 1 | 60.7% | +27.5% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
| BARRON, SEAN C | 1 | 52.7% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18301542 | TREATMENT OF INFLAMMATORY CONDITIONS | CORNELIUS, CLAIRE ADRIENNE | 31d overdue |
| 17929835 | STRUCTURE EVALUATION SYSTEM, STRUCTURE EVALUATION APPARATUS, AND STRUCTURE EVALUATION METHOD | KARAVIAS, DENISE R | 25d overdue |
| 17776556 | Combination Therapy Based on PD-1 Signaling Inhibitors | BENAVIDES, JENNIFER ANN | 21d |
| 18040563 | AMMONIA SYNTHESIS COMPOSITE CATALYST AND AMMONIA MANUFACTURING METHOD | RAJA, JAANZEB CHAANGEZ | 34d |
| 18039787 | METHOD FOR ISOLATING, FROM PLANT BIOMASS, AT LEAST ONE SELECTED FROM GROUP CONSISTING OF LIGNIN, HEMICELLULOSE, LIGNIN-POLYSACCHARIDE COMPOSITE, CELLULOSE, AND HEMICELLULOSE-CELLULOSE COMPOSITE | HEINCER, LIAM J | 61d |
| 19118319 | POWDER MATERIAL FOR THREE-DIMENSIONAL SHAPING, METHOD FOR MANUFACTURING THREE-DIMENSIONAL SHAPED ARTICLE, AND THREE-DIMENSIONAL SHAPED ARTICLE | JACKSON, MONIQUE R | — |
| 18861782 | Aquaculture Feed | SHELLHAMMER, JAMES PAUL | — |
| 18941910 | GAS SEPARATION SYSTEM, GAS SEPARATION METHOD, AND GAS SEPARATION AGENT | VASISTH, VISHAL V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18307564 | SEMICONDUCTOR LASER AND METHOD OF MANUFACTURING SAME | NELSON, HUNTER JARED | 31d overdue |
| 17916116 | TWO-DIMENSIONAL PHOTONIC-CRYSTAL LASER | NELSON, HUNTER JARED | 29d |
| 19118319 | POWDER MATERIAL FOR THREE-DIMENSIONAL SHAPING, METHOD FOR MANUFACTURING THREE-DIMENSIONAL SHAPED ARTICLE, AND THREE-DIMENSIONAL SHAPED ARTICLE | JACKSON, MONIQUE R | — |
| 18861782 | Aquaculture Feed | SHELLHAMMER, JAMES PAUL | — |
| 18871626 | HOLLOW SPHERICAL PARTICLES | GEMBEH, SHIRLEY V | — |
| 18941910 | GAS SEPARATION SYSTEM, GAS SEPARATION METHOD, AND GAS SEPARATION AGENT | VASISTH, VISHAL V | — |
| 18842493 | SILICON CARBIDE CERAMIC AND PRODUCTION METHOD THEREFOR | JANSSEN, REBECCA | — |
| 18835286 | METHOD FOR PRODUCING LUNG MESENCHYMAL CELLS AND LUNG MESENCHYMAL CELLS | SCHUBERG, LAURA J | — |
| Art Unit | Apps |
|---|---|
| 2828 | 4 |
| 1788 | 2 |
| 1653 | 2 |
| 1627 | 2 |
| 1736 | 2 |
| 1793 | 1 |
| 1615 | 1 |
| 1771 | 1 |
| 1621 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19118319 | POWDER MATERIAL FOR THREE-DIMENSIONAL SHAPING, METHOD FOR MANUFACTURING THREE-DIMENSIONAL SHAPED ARTICLE, AND THREE-DIMENSIONAL SHAPED ARTICLE | JACKSON, MONIQUE R | 1788 | §102§103 | Non-Final OA | — | Pending | Apr 03, 2025 |
| 18861782 | Aquaculture Feed | SHELLHAMMER, JAMES PAUL | 1793 | §102DP | Non-Final OA | — | Pending | Jan 29, 2025 |
| 18871626 | HOLLOW SPHERICAL PARTICLES | GEMBEH, SHIRLEY V | 1615 | §103DP | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18941910 | GAS SEPARATION SYSTEM, GAS SEPARATION METHOD, AND GAS SEPARATION AGENT | VASISTH, VISHAL V | 1771 | §102§103 | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18849105 | DRUG FOR TREATING OR PREVENTING CHARCOT-MARIE-TOOTH DISEASE | ARCORIA, PAUL JOSEPH | 1621 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18849133 | THERAPEUTIC OR PROPHYLACTIC MEDICINE FOR FRAGILE X SYNDROME | SHIAO, REI TSANG | 1691 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18842493 | SILICON CARBIDE CERAMIC AND PRODUCTION METHOD THEREFOR | JANSSEN, REBECCA | 1733 | §103 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18835286 | METHOD FOR PRODUCING LUNG MESENCHYMAL CELLS AND LUNG MESENCHYMAL CELLS | SCHUBERG, LAURA J | 1631 | §101§102 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18717354 | METHOD FOR PRODUCING NEURAL CREST CELLS SPECIALIZED FOR DIFFERENTIATION INTO MESENCHYMAL LINEAGE | BARRON, SEAN C | 1653 | §102§103§112 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18656496 | METHOD FOR PRODUCING CD8alpha+beta+ CYTOTOXIC T CELLS | BELYAVSKYI, MICHAIL A | 1644 | §103DP | Non-Final OA | — | Pending | May 06, 2024 |
| 18705160 | WHITE LIGNIN, WHITE LIGNIN-POLYSACCHARIDE COMPLEX, AND METHOD FOR PRODUCING SAME | FERRE, ALEXANDRE F | 1788 | §103 | Final Rejection | 14d | Pending | Apr 26, 2024 |
| 18703103 | MEDICAL AGENT INCLUDING ADJUVANT AND COMPOSITE OF PHOTOSENSITIVE MOLECULE AND MOLECULE BINDING TO CANCER-SPECIFIC CELL SURFACE MOLECULE | EDGINGTONGIORDANO, FRANCESCA | 1643 | §102§103 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18696154 | BIRD'S-EYE VIEW DATA GENERATION DEVICE, BIRD'S-EYE VIEW DATA GENERATION PROGRAM, BIRD'S-EYE VIEW DATA GENERATION METHOD, AND ROBOT | PHAM, ANNIE | 2662 | §103 | Final Rejection | — | Pending | Mar 27, 2024 |
| 18689758 | Improvement of Tumor Immunogenicity by Means of Splicing-Controlling Compound | BARSKY, JARED | 1628 | §102§103§112Other | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18689159 | SUPERCONDUCTING ROTATING MACHINE AND SHIP, AUTOMOBILE, AIRCRAFT, AND PUMP USING SAME | SUBRAMANIAN, VISWANATHAN | 2834 | §103 | Non-Final OA | 70d | Pending | Mar 05, 2024 |
| 18425914 | OXIDE CRYSTAL, CRYSTALLINE OXIDE FILM, CRYSTALLINE MULTILAYER STRUCTURE, SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD OF A CRYSTALLINE MULTILAYER STRUCTURE | GROOMS, NOA WILLIAM FRAN | 1759 | §102§103§112 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18574883 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING KIDNEY INJURY, AND AUTOPHAGY ACTIVATOR | HUI, SAN MING R | 1627 | §102 | Non-Final OA | 5d | Pending | Dec 28, 2023 |
| 18561924 | SUPERCONDUCTING CONDUCTOR AND WINDING | WARTALOWICZ, PAUL A | 1736 | §102§103 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18557948 | SOLID OXIDE ELECTROCHEMICAL CELL AND METHOD FOR PRODUCING SAME | WITTENBERG, STEFANIE S | 1795 | §103 | Non-Final OA | — | Pending | Oct 29, 2023 |
| 18551440 | BRAIN ACTIVITY STATE DETERMINATION DEVICE AND BRAIN ACTIVITY STATE DETERMINATION PROGRAM | MUTCHLER, CHRISTOPHER JOHN | 3792 | §101 | Final Rejection | — | Pending | Sep 20, 2023 |
| 18281791 | PHOTONIC CRYSTAL SURFACE-EMITTING LASER AND METHOD FOR MANUFACTURING THE SAME | NELSON, HUNTER JARED | 2828 | §103 | Final Rejection | — | Pending | Sep 13, 2023 |
| 18281175 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | KELLY-O'NEILL, YOLANDA LYNNETTE | 1692 | §102§103 | Final Rejection | — | Pending | Sep 08, 2023 |
| 18548716 | COMPOUND AND RADIOACTIVE LABELING COMPOUND | NESTOR, DONNA MICHELLE | 1627 | §103DP | Final Rejection | — | Pending | Sep 01, 2023 |
| 18266311 | PHOTONIC-CRYSTAL SURFACE EMITTING LASER AND MANUFACTURING METHOD THEREOF | EHRLICH, ALEXANDER JOSEPH | 2828 | §103 | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18039787 | METHOD FOR ISOLATING, FROM PLANT BIOMASS, AT LEAST ONE SELECTED FROM GROUP CONSISTING OF LIGNIN, HEMICELLULOSE, LIGNIN-POLYSACCHARIDE COMPOSITE, CELLULOSE, AND HEMICELLULOSE-CELLULOSE COMPOSITE | HEINCER, LIAM J | 1767 | §102§112 | Final Rejection | 61d | Pending | Jun 01, 2023 |
| 18307564 | SEMICONDUCTOR LASER AND METHOD OF MANUFACTURING SAME | NELSON, HUNTER JARED | 2828 | §103 | Final Rejection | 31d overdue | Pending | Apr 26, 2023 |
| 18301542 | TREATMENT OF INFLAMMATORY CONDITIONS | CORNELIUS, CLAIRE ADRIENNE | 1672 | §103§112Other | Non-Final OA | 31d overdue | Pending | Apr 17, 2023 |
| 18040563 | AMMONIA SYNTHESIS COMPOSITE CATALYST AND AMMONIA MANUFACTURING METHOD | RAJA, JAANZEB CHAANGEZ | 1736 | §102§103 | Non-Final OA | 34d | Pending | Feb 03, 2023 |
| 18002009 | CHIMERIC ANTIGEN RECEPTOR-EXPRESSING IMMUNOCOMPETENT CELLS | DHAR, MATASHA | 1632 | §103DP | Non-Final OA | — | Pending | Dec 15, 2022 |
| 17916116 | TWO-DIMENSIONAL PHOTONIC-CRYSTAL LASER | NELSON, HUNTER JARED | 2828 | §103 | Non-Final OA | 29d | Pending | Sep 30, 2022 |
| 17929835 | STRUCTURE EVALUATION SYSTEM, STRUCTURE EVALUATION APPARATUS, AND STRUCTURE EVALUATION METHOD | KARAVIAS, DENISE R | 2857 | §101§103§112 | Non-Final OA | 25d overdue | Pending | Sep 06, 2022 |
| 17797551 | GENETICALLY MODIFIED MEGAKARYOCYTE, MODIFIED PLATELET, AND METHODS RESPECTIVELY FOR PRODUCING SAID GENETICALLY MODIFIED MEGAKARYOCYTE AND SAID MODIFIED PLATELET | ABUZEINEH, HANAN ISAM | 1633 | §102§103 | Final Rejection | — | Pending | Aug 04, 2022 |
| 17783097 | Freeze-Dried Preparations Comprising Megakaryocytes and Platelets | TICHY, JENNIFER M.H. | 1653 | §103 | Final Rejection | — | Pending | Jun 07, 2022 |
| 17776556 | Combination Therapy Based on PD-1 Signaling Inhibitors | BENAVIDES, JENNIFER ANN | 1675 | §102§103§112 | Non-Final OA | 21d | Pending | May 12, 2022 |
| 17419932 | TEST METHOD FOR ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS | XIE, XIAOZHEN | 1674 | §112 | Non-Final OA | — | Pending | Jun 30, 2021 |
| 17289970 | METHOD FOR PRODUCING PLURIPOTENT STEM CELL HAVING RELEASED DIFFERENTIATION RESISTANCE TO MESENDODERM | GAO, ASHLEY HARTMAN | 1678 | §103§112Other | Final Rejection | — | Pending | Apr 29, 2021 |
| 16768462 | MAINTENANCE-AND-AMPLIFICATION METHOD AND DIFFERENTIATION INDUCTION METHOD FOR PRIMORDIAL GERM CELLS/PRIMORDIAL GERM CELL-LIKE CELLS | TIWARI, VYOMA SHUBHAM | 1634 | §112 | Final Rejection | 56d | Pending | May 29, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKyoto University has 37 pending office actions as of October 2026, spread across 30 art units and 35 examiners.
Hunter Jared Nelson has the most, with 3 of Kyoto University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
